Your session is about to expire
Ozempic vs Bydureon
Introduction
For patients with type 2 diabetes, certain medications that alter the concentrations of glucose in the bloodstream can help in maintaining glycemic control and managing symptoms. Ozempic and Bydureon are two such drugs that are prescribed for this condition. Both these medications belong to a category known as glucagon-like peptide-1 (GLP-1) receptor agonists which work by stimulating insulin production after meals, thereby reducing blood sugar levels. Ozempic is an injectable medication given once weekly, offering additional benefits like weight loss and cardiovascular risk reduction. On the other hand, Bydureon also administered weekly but differs slightly in its chemical structure from Ozempic; it may not have as profound effects on weight or heart disease risk according to some studies.
Ozempic vs Bydureon Side By Side
| Attribute | Ozempic | Bydureon |
|---|---|---|
| Brand Name | Ozempic | Bydureon |
| Contraindications | Should not be taken if using other GLP-1 receptor agonists, not recommended for people who have had pancreatitis, risk of thyroid C-cell tumors, not for patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). | Should not be taken if using other GLP-1 receptor agonists, not recommended for people who have had pancreatitis, risk of thyroid C-cell tumors, not for patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). |
| Cost | $800 for 2 pens (0.5 mg) | $730 for 4 pens (2 mg) |
| Generic Name | Semaglutide | Exenatide |
| Most Serious Side Effect | Signs of thyroid tumors or cancer, severe stomach problems, changes in vision, low blood sugar, kidney problems. | Signs of an allergic reaction, severe abdominal pain, changes in vision, kidney problems, rapid heartbeat. |
| Severe Drug Interactions | Not specified, but caution advised with SGLT2 inhibitors due to dehydration risk. | Not specified, but caution advised with drugs that may affect gastrointestinal motility. |
| Typical Dose | 0.25 mg to 1 mg once weekly | 2 mg once per week |
What is Ozempic?
Semaglutide (the generic name for Ozempic) is a glucagon-like peptide-1 (GLP-1) receptor agonist class of medication used to improve blood sugar control in adults with type 2 diabetes. It was first approved by the FDA in 2017. Ozempic works by mimicking the function of GLP-1, a hormone that increases insulin secretion and decreases glucagon secretion, effectively helping lower blood sugar levels for longer periods than usual. Bydureon (extended-release exenatide), on the other hand, also belongs to the same class of drugs but it was approved earlier than Ozempic in 2012. Both these medications are injectable and assist in managing weight besides controlling blood sugar levels. However, compared to Bydureon's once-weekly injection requirement, Ozempic needs to be injected once weekly initially and then can be increased to a higher dose after five weeks based on individual requirements and tolerability which makes it more flexible as per patient’s therapeutic response.
What conditions is Ozempic approved to treat?
Ozempic is approved for the treatment of certain conditions:
- Type 2 diabetes as an adjunct to diet and exercise
- To reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes mellitus and established cardiovascular disease.
How does Ozempic help with these illnesses?
Ozempic aids in managing type 2 diabetes by mimicking the function of a hormone called glucagon-like peptide-1 (GLP-1). This hormone plays an essential role in regulating blood sugar levels, stimulating the release of insulin when glucose levels rise and inhibiting the release of glucagon which raises glucose levels. It accomplishes this by binding to GLP-1 receptors on cells in the pancreas and other tissues, helping maintain steady blood sugar levels for longer periods. However, natural GLP-1 is quickly broken down within minutes due to an enzyme known as DPP4. Ozempic has been designed to be resistant to this breakdown process allowing it stay active in body for up to one week. Hence, with its ability to mimic GLP-1 without getting rapidly metabolized, Ozempic can help manage diabetes effectively by maintaining stable blood sugar levels over time.
What is Bydureon?
Bydureon is a brand name for exenatide, which is an injectable drug used in the treatment of type 2 diabetes. It falls under the category of glucagon-like peptide-1 (GLP-1) receptor agonists, meaning it binds to GLP-1 receptors and stimulates insulin secretion while inhibiting glucagon release. This results in lowered blood glucose levels. Bydureon was approved by the FDA in 2012.
Unlike Ozempic, Bydureon does not directly stimulate insulin synthesis or beta cell proliferation but rather induces satiety and delays gastric emptying. Its differential action means its side-effect profile varies from that of other GLP-1 analogs such as Ozempic; notably, it doesn't cause weight loss to the same degree but still offers significant benefits including improved glycemic control with low risk of hypoglycemia. The effects on glucose metabolism can be particularly beneficial for managing type 2 diabetes especially in patients who don't respond favorably to standard treatments like metformin.
What conditions is Bydureon approved to treat?
Bydureon is an FDA-approved medication for the following conditions:
- Type 2 diabetes mellitus as an adjunct to diet and exercise
- It can also be used in combination with other oral antidiabetic agents or insulin when these alone do not provide adequate glycemic control.
How does Bydureon help with these illnesses?
Bydureon, like Ozempic, is a glucagon-like peptide-1 (GLP-1) receptor agonist class of medication which plays an important role in glucose regulation and insulin secretion. This type of drug mimics the natural hormone GLP-1 to increase insulin production when blood sugar levels are high and reduce the amount of glucose produced by the liver, thus helping manage Type 2 Diabetes. Bydureon stands out due to its convenient once-weekly dosing schedule that allows slower release into your system over time compared to other drugs such as Ozempic. It may also contribute towards weight loss alongside managing blood sugar levels. However, it doesn't significantly affect serotonin or norepinephrine levels hence it's generally not prescribed for depression treatment but primarily focuses on diabetes management.
How effective are both Ozempic and Bydureon?
Both semaglutide (Ozempic) and exenatide (Bydureon) are GLP-1 receptor agonists, used to manage blood sugar levels in type 2 diabetes patients. They were initially approved by the FDA a decade apart, with Bydureon receiving approval in 2012 and Ozempic in 2017. Since they act on the same receptors but have different molecular structures and dosing schedules, they may be prescribed under varying circumstances.
The effectiveness of semaglutide and exenatide was directly compared in a randomized clinical trial conducted over 56 weeks; both drugs showed efficacy in managing blood glucose levels as well as similar safety profiles. However, this study found that those on semaglutide experienced greater reductions in HbA1c levels – an indicator of average plasma glucose concentration –and weight loss than those taking exenatide.
In terms of side effects, both medications can cause gastrointestinal issues such as nausea or vomiting but these typically decrease over time. A key difference between them is their administration: while Ozempic is given once weekly via subcutaneous injection at any time during the day irrespective of meals; Bydureon also requires once-weekly injections but should ideally be administered at meal times.
While Ozempic has shown superior results when it comes to controlling blood sugar levels and aiding weight loss, Bydureon still remains an important treatment option for type-2 diabetics who do not respond well to other forms of medication or have specific needs based on their lifestyle or co-existing conditions.
Related trials for ozempic and bydureon
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Ozempic typically prescribed?
Dosages of Ozempic range from 0.25 mg to 1 mg once weekly, with most individuals starting at the lower end and increasing as their bodies adjust or if blood sugar control is not adequate. By contrast, Bydureon is typically administered in a consistent dose of 2 mg once weekly. For either drug, it's important to note that these are injectable medications used for type 2 diabetes and adjustments should be made under medical supervision. The maximum dosage for Ozempic should not exceed 1 mg per week while Bydureon maintains its standard dose of 2 mg per week.
At what dose is Bydureon typically prescribed?
Bydureon treatment typically begins with a dosage of 2 mg once per week. This is administered through a subcutaneous injection, which can be given at any time of the day, on any day of the week without regard to meals. The same dose can be continued for several weeks and there's no need for incremental increases. In terms of maximum dosage, Bydureon should not exceed 2 mg per week. It is important to note that it may take some weeks for patients to see an improvement in their blood glucose levels due to its mechanism of action.
What are the most common side effects for Ozempic?
Common side effects of Ozempic may include:
- Nausea
- Diarrhea
- Abdominal pain or discomfort (dyspepsia)
- Decreased appetite
- Vomiting
- Constipation
On the other hand, Bydureon can cause these common side effects:
- Nausea, vomiting, diarrhea
- Minor skin irritation at the injection site
- Itchy skin or a rash
- Headache
- Loss of appetite
It is important to note that everyone responds differently to medications and the listed side effects are not experienced by all individuals. If you experience any persistent or severe symptoms while taking either medication, promptly seek medical attention.
Are there any potential serious side effects for Ozempic?
While both Ozempic and Bydureon are used in the treatment of type 2 diabetes, their potential side effects can differ. Here are some possible serious side effects associated with Ozempic:
- Signs of thyroid tumors or cancer: a lump or swelling in your neck, hoarseness, trouble swallowing, shortness of breath.
- Allergic reactions including itching, rash, hives on your skin; swelling of your face, lips, tongue or throat; difficulty breathing or swallowing; feeling faint.
- Severe stomach problems: severe abdominal pain that does not go away and vomiting may be symptoms of pancreatitis.
- Changes in vision such as blurred vision
- Low blood sugar (hypoglycemia): symptoms include shaking, sweating excessively at night time especially if using insulin along with it.
- Kidney problems (kidney failure). If you have kidney problems and take certain medicines known as SGLT2 inhibitors with Ozempic®, you may get dehydrated which may lead to worsening kidney function.
If you experience any adverse reaction while taking this medication stop use immediately and consult with your healthcare provider.
What are the most common side effects for Bydureon?
Bydureon, an injectable medication for type 2 diabetes management, presents several potential side effects:
- Nausea and vomiting
- Diarrhea or constipation
- Minor weight loss
- Itching or a lump at the injection site
- Headache
- Dizziness and fatigue
- Mild stomach pain
Rare but serious side effects can include rapid heartbeat, confusion or mood changes. Despite these possible side effects, Bydureon has proven beneficial to many in managing their blood sugar levels when combined with diet and exercise. Always consult your healthcare provider regarding any concerns about medication side effects.
Are there any potential serious side effects for Bydureon?
While Bydureon is generally safe, there are potential serious side effects to be aware of. If you experience any of the following symptoms, immediately consult your healthcare provider:
- Signs of an allergic reaction such as rash, hives, or swelling in the face, lips or throat that could cause difficulty breathing.
- Unusual changes in mood or behavior and confusion.
- Severe abdominal pain which may radiate to your back with or without vomiting; these could be signs of pancreatitis.
- Changes in vision including blurred vision and trouble seeing clearly
- Kidney problems: change in amount or color of urine output
- Rapid heartbeat which might feel like a fluttering sensation in your chest It's important to note that some patients on Bydureon have reported feeling more anxious than usual and having sleep-related issues.
Contraindications for Ozempic and Bydureon?
Both Ozempic and Bydureon, as with other medications used to treat type 2 diabetes, may cause some adverse reactions in certain individuals. If you notice any severe side effects such as difficulty breathing or swallowing, swelling of your face, lips, tongue or throat (signs of a serious allergic reaction), please seek immediate medical attention.
Neither Ozempic nor Bydureon should be taken if you are taking, or have been using GLP-1 receptor agonists. It is crucial that you always disclose to your healthcare provider which medications you are currently taking; GLP-1 receptor agonists will require a period of about several hours to clear from the system to prevent dangerous interactions with Ozempic and Bydureon.
Additionally, these drugs are not recommended for people who have had pancreatitis. They also carry a risk of thyroid C-cell tumors and should not be used by patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
How much do Ozempic and Bydureon cost?
For the brand name versions of these drugs:
- The price of 2 pens of Ozempic (0.5 mg) averages around $800, which works out to approximately $14/day for a weekly dose.
- The price of 4 pens Bydureon BCise (2 mg) is about $730, working out to roughly $26 per week or about $3.70/day.
In this comparison, if you are taking a single weekly dose as recommended for both drugs, then Ozempic is less expensive on a per-day treatment basis than Bydureon. However, cost should not be the primary consideration in determining which drug is right for you.
Please note that currently there are no generic versions available for either Ozempic (semaglutide) or Bydureon (exenatide). Prices can vary and may be influenced by insurance coverage and location where the medication is purchased.
Popularity of Ozempic and Bydureon
Semaglutide, in its brand form as Ozempic, was estimated to have been prescribed to about 1.8 million people in the US in 2020. Semaglutide accounted for just over 7% of GLP-1 receptor agonist prescriptions in the United States. As a new-generation antidiabetic drug, it has been increasingly popular since its introduction due to its once-weekly dosing and overall efficacy.
Exenatide extended-release, well-known by its brand name Bydureon, was prescribed to approximately 800 thousand people within the same year. It accounts for almost under 4% of GLP-1 receptor agonist prescriptions and is known for managing blood sugar levels effectively while promoting weight loss which makes it an attractive option for diabetic patients with obesity or overweight conditions. However, despite being on the market longer than semaglutide, exenatide's growth rate has remained steady over the past decade.
Conclusion
Both Ozempic (semaglutide) and Bydureon (exenatide) are long-acting injectable medications used in the treatment of type 2 diabetes. They belong to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists which work by stimulating the release of insulin, slowing gastric emptying, and reducing levels of glucagon - all actions that lead to lower blood glucose levels.
In some cases, these two drugs may be combined with other diabetes medicines but this requires careful consideration due to potential drug interactions or contraindications. Their different pharmacokinetic profiles mean they are often prescribed under different circumstances: Ozempic is administered once weekly whereas Bydureon is given every seven days.
At present, neither Ozempic nor Bydureon are available as generics, meaning cost can be a significant factor for patients paying out-of-pocket. Both medications may also require an adjustment period with effects not immediately noticeable.
The side effect profile for both medicines includes gastrointestinal issues such as nausea and vomiting being common; however, these typically decrease over time as your body gets used to the medication. It's recommended that patients monitor their blood sugar regularly while taking either medication and report any unusual symptoms or changes in health status promptly to their healthcare provider.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Dhillon, S. (2018, January 23). Semaglutide: First Global Approval. Drugs. Springer Science and Business Media LLC.http://doi.org/10.1007/s40265-018-0871-0
- Aroda, V. R., Ahmann, A., Cariou, B., Chow, F., Davies, M. J., Jódar, E., … Lingvay, I. (2019, October). Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials. Diabetes & Metabolism. Elsevier BV.http://doi.org/10.1016/j.diabet.2018.12.001
- Scott, L. J. (2012, August). Exenatide Extended-Release. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/11209750-000000000-00000
- Syed, Y. Y., & McCormack, P. L. (2015, June 13). Exenatide Extended-Release: An Updated Review of Its Use in Type 2 Diabetes Mellitus. Drugs. Springer Science and Business Media LLC.http://doi.org/10.1007/s40265-015-0420-z
- Drucker, D. J., Buse, J. B., Taylor, K., Kendall, D. M., Trautmann, M., Zhuang, D., & Porter, L. (2008, October). Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. The Lancet. Elsevier BV.http://doi.org/10.1016/s0140-6736(08)61206-4